Themis Medicare: No Physical Share Transfer Requests Re-lodged in Oct-Nov 2025
Themis Medicare Limited reported no re-lodgement of physical share transfer requests for October and November 2025, as per SEBI's special window. This confirmation was provided by their RTA, MUFG Intime India Private Limited.
This is a routine compliance filing and does not involve any significant financial or operational changes for the company, hence the impact is low.
The announcement is a routine regulatory filing confirming no activity related to share transfers, hence it is neutral.
Themis Medicare Limited has submitted a report regarding the "Ease of Doing Investment – Special Window for Re-lodgement of Transfer Requests of Physical Shares" as per SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 02, 2025.
According to the report provided for the months of October and November 2025, and confirmed by the company's Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited, there were no cases for the re-lodgement of transfer requests for physical shares received during this period.
This information is for the information and record of the stock exchanges.
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under share transfer updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.